Fabian Raemy, Contributing Author LYNX SEO

There is a sourcing decision that separates cannabis brands with the most loyal repeat customers from those quietly cycling through SKU reformulations every 18 months. It is not the cannabinoid. It is not the hardware. It is not even the price point.

It is whether the terpenes in the product came from the cannabis plant – and if so, how.

The brands that are easiest to identify right now – the ones whose products smell the same from batch to batch, feel the same from purchase to purchase, and consistently outperform the category on repeat purchase – made this call early.

The operators who treated terpenes as a procurement afterthought are now discovering that experienced cannabis consumers have gotten educated fast. The gap between what a product promises and what it actually delivers is legible in a way it was not three years ago.

This is the operational and business case for getting the terpene decision right before a product enters production.

The Sourcing Spectrum: What Operators Are Choosing Between

Brands building cannabis products today have three broad terpene input categories available. The differences between them are not primarily about aroma. They are about what shows up in the finished product and how it behaves across batches, across consumers, and across shelf life.

Synthetic Terpenes

Synthetic terpenes are manufactured flavor compounds. Molecularly, an isolated synthetic linalool is identical to naturally occurring linalool.

The problem is profile depth. A synthetic blend typically assembles a handful of isolated compounds to approximate a target strain – maybe five to eight major terpenes. What it cannot replicate is the hundreds of trace and minor compounds present in actual cannabis essential oil, the compounds that create what researchers describe as the entourage effect and what experienced consumers recognize as authenticity.

Several states, including New York, Michigan, and Nevada, have also moved to restrict synthetic terpenes on consumer safety grounds – adding regulatory risk on top of the formulation limitations.

Botanical Terpenes

Botanical terpenes are extracted from non-cannabis plants – citrus peels, pine trees, lavender, rosemary – and blended to approximate cannabis strain profiles. The raw materials are abundant, costs are lower, and for operators whose primary concern was getting to launch, botanical blends were the obvious path. Most of the category defaulted here.

The problem is what the blend is missing. When you compare a gas chromatography readout of a botanical “Jack Herer” blend against a full-spectrum cannabis essential oil of the same cultivar, the gap is not subtle. The cannabis oil shows dozens of additional peaks that the botanical profile simply does not have. Those peaks are not decorative. They are the product.

Cannabis-Derived Terpenes (Full-Spectrum Essential Oils)

Full-spectrum cannabis essential oils, captured from live plant material at peak ripeness, are the sourcing decision the most consistent brands made early.

At scale, producing CDTs properly is genuinely difficult:

• Terpene yield per gram of fresh flower is very low
• The extraction process is sensitive to harvest timing and handling conditions
• The material is perishable in ways that cannabinoids are not
• Very few suppliers have solved this at commercial volumes

That difficulty is exactly why the market defaulted to botanical blends. It is also why the brands that solved the CDT supply chain problem have a durable competitive advantage.

Why This Decision Compounds Over Time

The terpene sourcing decision does not stay contained to the formulation. It becomes a business model question within two or three production cycles.

Batch Consistency

This is where the compounding effect is most visible. Botanical blends can be reproduced precisely because they are assembled from isolated compounds against a fixed spec. Cannabis essential oils sourced from live plant material carry inherent agricultural variability – harvest timing, microclimate, plant maturity – which means that without a supply chain specifically engineered around consistency, batches shift.

Flavor notes drift. Consumer feedback starts reading like two different products with the same label. The brands that avoided this problem did not do so by switching back to botanical inputs. They solved it at the supply chain level – sourcing from vertically integrated producers who control genetics, cultivation, harvest timing, and extraction under one roof, producing the same cultivars season over season.

Effect Reproducibility

When a consumer buys a vape cartridge or infused product a second time, they are not just purchasing an aroma – they are purchasing an experience they want to repeat.

Synthetic and botanical profiles can approximate the major terpene peaks that drive a strain’s character. What they cannot replicate is the complete natural ratio of trace compounds present in full-spectrum cannabis essential oil – compounds that research increasingly links to the distinctive character of different cannabis chemovars. Consumer perception studies consistently find that experienced buyers can distinguish cannabis-derived profiles from botanical recreations, and preference tracks decisively toward the authentic input.

Shelf Performance

Terpene sourcing also shows up in shelf behavior in ways that catch operators off guard. Research on terpene stability confirms that terpenes are highly sensitive to heat, light, and oxygen – and that degradation begins at harvest if material is not handled correctly.

Formulations built on properly extracted full-spectrum cannabis essential oils tend to be more shelf-stable than those built from botanical reconstructions, because the plant’s original chemistry – including natural antioxidant compounds – remains intact.

Operators who discover off-flavor development or terpene drift after products are already in distribution are almost always tracing it back to extraction practices or sourcing inputs that were not designed for the application.

What “Vertically Integrated” Means for Terpenes

The phrase gets used loosely in cannabis. For terpene sourcing, vertical integration means something specific: the same operation controls the genetics being grown, the cultivation conditions optimized for terpene expression, the harvest timing, and the extraction process that converts live plant material into a stable, commercially usable oil.

Terpene Belt Farms is a useful reference point here because the company was purpose-built around this problem. Operating since 2019 in California’s San Joaquin Valley, they run what they call the Fresh Never Frozen® process: plants are harvested at peak ripeness and processed on-site within minutes of harvest, without drying, curing, or freezing. Extraction is solventless and designed to capture the full essential oil profile of each cultivar, leaving cannabinoids behind.

Key operational details that matter to formulation buyers:

• The on-site facility processes over ten tons of fresh plant material per hour
• Each cultivar or blend is assigned a standardized number – not a strain name – and produced season over season against that spec
• Oils are cannabinoid-free, making them compliant for interstate commerce under the 2018 Farm Bill
• The company provides full phytoprint® (terpene composition breakdowns) and COAs with every batch

That last point – the standardized numbering system – is more important than it sounds. A brand can only build nationally standardized formulations if their inputs are standardized first. Calling a product “#7” and farming it to the same spec each season is how you make that possible.

The Terpene Decision as a Consumer Loyalty Problem

The operators who skipped this decision are not hard to identify. Their customer feedback tends to follow a pattern: strong initial reception, then complaints about inconsistency a few months in – different flavor than before, different effect character, why did you change the formula.

The formula often has not changed. What changed is:

• The terpene blend shifted between batches from the supplier
• The botanical profile never fully captured the experience the marketing described
• Enough consumers tried the product twice to notice the gap

This is a more serious business problem than it initially appears. Repeat purchase in cannabis – particularly in vapes and infused products where consumers make deliberate brand choices – runs on trust.

A consumer who cannot reliably reproduce an experience from your product does not immediately become a detractor. They become indifferent. They try the next brand on the shelf. In a category where new SKUs proliferate faster than consumer attention, indifference and attrition are effectively the same outcome.

The Cost Argument Is Weaker Than Operators Think

The per-unit cost difference between botanical blends and genuine cannabis-derived terpenes in most finished formulations is modest – often within a few cents to roughly ten cents per unit, depending on incorporation rate and product format.

That delta looks larger in a spreadsheet than it performs in the market. Against it, operators should be weighing:

• Reformulation costs when batch drift forces a product adjustment
• Customer acquisition costs to replace buyers who tried the product twice and moved on
• Brand equity erosion when early adopters – the consumers who write reviews and talk to their peers – find the product inconsistent
• Retail risk if a buyer pulls a SKU after subpar velocity driven by consumer experience

The brands that priced their terpene inputs correctly at launch are the ones not paying for those downstream costs now.

What the Best Operators Did Differently

The cannabis brands with the most defensible consumer loyalty positions did not make formulation decisions based primarily on input cost. They made them based on what the finished product needed to do – reliably, at volume, across market conditions.

For terpenes, that meant sourcing from operations built around agricultural quality and extraction consistency. The Fresh Never Frozen® approach from Terpene Belt Farms is one concrete example of what that looks like at industrial scale: a supply chain designed not around what was cheapest to produce, but around what was actually required to deliver a consistent full-spectrum cannabis experience from one production run to the next.

That is a different starting point from most of the category, where brand identity gets built first and formulation gets sourced to whatever is available at acceptable cost.

Where This Leaves Operators Making Decisions Now

The cannabis category is consolidating around brands that can execute consistently – on shelf stability, on flavor, and on consumer experience. The brands that are going to matter in this category’s next chapter are the ones whose products a consumer can learn.

The terpene sourcing decision is where that reliability starts. The operators who made the right call early know it. The ones who did not are starting to find out.